Author Question: Johnson Enterprises is recruiting candidates to fill the new position of ombudsperson. Johnson is ... (Read 82 times)

sc00by25

  • Hero Member
  • *****
  • Posts: 596
Johnson Enterprises is recruiting candidates to fill the new position of ombudsperson. Johnson is most likely adding this position to ________.
 
  A) handle internal problems before they become lawsuits
  B) negotiate with local and national labor unions
  C) monitor the firm's retention and turnover rates
  D) assist HR with compensation decisions

Question 2

Outplacement helps employers preserve their reputation while softening the impact of displacement.
 
  Indicate whether this statement is true or false.



CAPTAINAMERICA

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

Answer: A

Answer to Question 2

Answer: TRUE



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library